AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H901. A total of 5 filers reported holding AMYLYX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,259,454 | +4.2% | 123,400 | +22.8% | 0.01% | +14.3% |
| Q2 2023 | $2,167,785 | -6.2% | 100,500 | +27.5% | 0.01% | -12.5% |
| Q1 2023 | $2,311,992 | +10.2% | 78,800 | +38.7% | 0.01% | +60.0% |
| Q4 2022 | $2,098,760 | -82.5% | 56,800 | -86.7% | 0.01% | -79.2% |
| Q3 2022 | $12,026,000 | +304.1% | 427,200 | +176.5% | 0.02% | +380.0% |
| Q2 2022 | $2,976,000 | +99100.0% | 154,500 | +77150.0% | 0.01% | – |
| Q1 2022 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 22,300 | $22,969 | 0.01% |
| GROUP ONE TRADING, L.P. | 123,400 | $2,259,454 | 0.01% |
| JANE STREET GROUP, LLC | 278,400 | $5,097,504 | 0.00% |
| SIMPLEX TRADING, LLC | 164,500 | $3,011 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |